Logo image of CLOV

CLOVER HEALTH INVESTMENTS CO (CLOV) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:CLOV - US18914F1030 - Common Stock

2.58 USD
-0.08 (-3.01%)
Last: 12/5/2025, 8:10:50 PM
2.62 USD
+0.04 (+1.55%)
After Hours: 12/5/2025, 8:10:50 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CLOV revenue by date.CLOV revenue by date.
3.477B
136.19%
1.261B
-63.74%
1.371B
8.77%
1.942B
41.63%
2.674B
37.69%
3.05B
14.06%
3.376B
10.69%
3.766B
11.55%
4.445B
18.03%
5.757B
29.52%
EBITDA
YoY % growth
CLOV ebitda by date.CLOV ebitda by date.
-369.71M
41.85%
-177.054M
52.11%
-44.13M
75.08%
20.083M
145.51%
50.479M
151.35%
81.773M
61.99%
N/AN/AN/AN/A
EBIT
YoY % growth
CLOV ebit by date.CLOV ebit by date.
-370.9M
41.77%
-179.563M
51.59%
-45.461M
74.68%
-90.973M
-100.11%
-21.318M
76.57%
50.597M
337.34%
133.26M
163.38%
199.89M
50.00%
288.95M
44.55%
359.8M
24.52%
Operating Margin
CLOV operating margin by date.CLOV operating margin by date.
-10.67%-14.24%-3.32%-4.68%-0.80%1.66%3.95%5.31%6.50%6.25%
EPS
YoY % growth
CLOV eps by date.CLOV eps by date.
-0.74
41.52%
-0.44
40.94%
-0.09
79.55%
-0.18
-96.44%
-0.03
84.61%
0.04
231.23%
0.19
442.86%
0.31
57.89%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.11
-163.49%
0.010.01
167.98%
0.00
100.00%
-0.06
38.71%
0.03
349.78%
0.03
125.06%
0.01-0.05
21.05%
Revenue
Q2Q % growth
476.4M
41.38%
663.53M
43.52%
680.41M
42.46%
679.03M
36.72%
610.75M
28.20%
655.13M
-1.27%
659.26M
-3.11%
636.63M
-6.24%
640.55M
4.88%
EBITDA
Q2Q % growth
-25.87M
-31.52%
26.255M
3,349.38%
21.883M
325.62%
13.373M
157.86%
4.17M
116.12%
46.685M
77.81%
43.013M
96.56%
33.334M
149.26%
1.489M
-64.29%
EBIT
Q2Q % growth
-44.461M
-111.72%
68.85K
105.40%
1.813M
117.17%
-6.637M
72.77%
-32.462M
26.99%
46.288M
67,130.21%
42.616M
2,250.58%
32.936M
596.24%
1.081M
103.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.05
-150.00%
-0.03-0.02-63.40%
Q2 2025
Q2Q % growth
-0.02
-300.00%
-0.030.0128.70%
Q1 2025
Q2Q % growth
0.00
100.00%
-0.060.06100.00%
Q4 2024
Q2Q % growth
-0.04
71.43%
-0.070.0339.67%
Q3 2024
Q2Q % growth
-0.02
77.78%
-0.040.0250.98%
Q2 2024
Q2Q % growth
0.01
116.67%
-0.050.06120.14%
Q1 2024
Q2Q % growth
-0.04
73.33%
-0.070.0345.78%
Q4 2023
Q2Q % growth
-0.14
20.00%
-0.140.001.49%
Q3 2023
Q2Q % growth
-0.09
43.75%
-0.110.0216.50%
Q2 2023
Q2Q % growth
-0.06
72.73%
-0.150.0960.89%
Q1 2023
Q2Q % growth
-0.15
21.05%
-0.180.0316.35%
Q4 2022
Q2Q % growth
-0.18
38.38%
-0.260.0932.77%
Q3 2022
Q2Q % growth
-0.16
-100.00%
-0.240.0834.37%
Q2 2022
Q2Q % growth
-0.22
71.79%
-0.21-0.01-4.60%
Q1 2022
Q2Q % growth
-0.19
-46.15%
-0.280.0931.87%
Q4 2021
Q2Q % growth
-0.28
-42.00%
-0.27-0.02-5.80%
Q3 2021
Q2Q % growth
-0.08 -0.230.1565.64%
Q2 2021
Q2Q % growth
-0.78 -0.14-0.64-465.07%
Q1 2021
Q2Q % growth
-0.13 -0.11-0.02-15.16%
Q4 2020
Q2Q % growth
-0.20 -0.860.6676.66%
CLOV Yearly EPS VS EstimatesCLOV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -0.5 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
496.65M
50.05%
480.51M16.14M3.36%
Q2 2025
Q2Q % growth
477.62M
34.07%
477.66M-40K-0.01%
Q1 2025
Q2Q % growth
462.331M
33.27%
489.07M-26.739M-5.47%
Q4 2024
Q2Q % growth
336.963M
-33.96%
390.2M-53.237M-13.64%
Q3 2024
Q2Q % growth
330.986M
-31.34%
353.2M-22.214M-6.29%
Q2 2024
Q2Q % growth
356.26M
-30.64%
345.54M10.72M3.10%
Q1 2024
Q2Q % growth
346.922M
-34.27%
327.65M19.272M5.88%
Q4 2023
Q2Q % growth
510.251M
-43.23%
489.86M20.391M4.16%
Q3 2023
Q2Q % growth
482.066M
-43.74%
504.49M-22.424M-4.44%
Q2 2023
Q2Q % growth
513.628M
-39.34%
500.64M12.988M2.59%
Q1 2023
Q2Q % growth
527.775M
-39.64%
508.71M19.065M3.75%
Q4 2022
Q2Q % growth
898.8M
108.06%
801.09M97.71M12.20%
Q3 2022
Q2Q % growth
856.8M
100.56%
815.45M41.35M5.07%
Q2 2022
Q2Q % growth
846.7M
105.26%
830.91M15.79M1.90%
Q1 2022
Q2Q % growth
874.4M
336.55%
803.16M71.24M8.87%
Q4 2021
Q2Q % growth
432M 416.3M15.7M3.77%
Q3 2021
Q2Q % growth
427.2M 421.36M5.84M1.39%
Q2 2021
Q2Q % growth
412.5M 209.49M203.01M96.91%
Q1 2021
Q2Q % growth
200.3M 196.42M3.88M1.98%
Q4 2020
Q2Q % growth
170.3M-170.3M-100.00%
CLOV Yearly Revenue VS EstimatesCLOV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-54.99% -87.87% -62.49% -44.44%
Revenue0% -1.23% 0.83% 1.25%